Abstract:Background Peripheral arterial disease (PAD) is highly prevalent and particularly in elders, smokers, diabetics or patients with systemic atherosclerosis. Apart from the surgery and medication, stem cell transplantation offers promising approaches for therapeutic angiogenesis and tissue repair. In this study we try to use in vivo multimodality molecular imaging strategies to investigate adipose tissue-derived mesenchymal stem cells (MSCs) survival, function and relative mechanism. Method MSCs were cultured from murine adipose tissue from transgenic mice, which carried double reporter genes: firefly luciferase (Fluc) and enhanced green fluorescent protein (eGFP), by collagenase digestion method. Hindlimb ischaemia animal model was created in male nude mice by ligating the proximal and distal femoral artery. MSCs (1×105) along with/without VEGF (0.4 ng) were transplanted into ischaemic hindlimb. The animals were subjected to be imaged by bioluminescence imaging and CT scan. Laser Doppler perfusion imaging (LDPI) were used to show the spatiotemporal images of peripheral tissue blood perfusion. Micro-CT, histological and molecular analysis were tested to confirm the cells9 location and angiogenesis anatomically and mechanically. Result The colour-coded index of LDPI was significantly higher in the MSCs-transplanted group than that in the control group from day 3 to 28 post cell transplantation. On day 3 after transplantation, the bioluminescence signals in MSCs with VEGF group were 4.6×106±2.5×105 photons/s/cm2/sr, while in MSCs group were 2.8×106±3.1×105 photons/s/cm2/sr, respectively (p<0.01 vs control). The signals of bioluminescence increased gradually from POD 3 to day 21, which proved survival and proliferation of the MSCs in the host. The group treated with MSCs and VEGF showed higher signals than that injected by MSCs only, which indicated the reinforcement of VEGF. Micro-CT angiography demonstrated more angiogenesis in the hindlimbs of the treated mice on day 21, which were also confirmed by molecular analysis. Histological analysis showed that MSCs therapy recovered vessel density compared with the control group. Conclusion Bioluminescence fusion with CT scan provides higher detailed 3D imaging for monitoring MSCs in vivo. Angiogenesis activator VEGF might promote MSCs9 beneficial function for hindlimb ischaemia therapy.

Transplantation of Placenta‐derived Mesenchymal Stem Cells Enhances Angiogenesis after Ischemic Limb Injury in Mice

Transplantation Of Mesenchymal Stem Cells Enhances Angiogenesis After Ischemic Limb Injury In Mice

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats.

Delivery of placenta-derived mesenchymal stem cells ameliorates ischemia induced limb injury by immunomodulation.

Genetically Modified Human Placenta-Derived Mesenchymal Stem Cells with Fgf-2 and Pdgf-Bb Enhance Neovascularization in A Model of Hindlimb Ischemia

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice

Abstract 328: Enhanced Therapeutic Effects of Mesenchymal Stem Cells for Hindlimb Ischemia by a Nitric Oxide Hydrogel Through Mesenchymal-endothelial Transition

Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.

Placenta Mesenchymal Stem Cell Accelerates Wound Healing by Enhancing Angiogenesis in Diabetic Goto-Kakizaki (GK) Rats.

Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model

Human-Induced Pluripotent Stem-Cell-Derived Smooth Muscle Cells Increase Angiogenesis to Treat Hindlimb Ischemia

Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia

Ultrasound-induced Microbubble Destruction Promotes Targeted Delivery of Adipose-Derived Stem Cells to Improve Hind-Limb Ischemia of Diabetic Mice.

Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Attenuate Limb Ischemia by Promoting Angiogenesis in Mice

Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration

Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice

Abstract 406: Plasminogen Regulates Mesenchymal Stem Cell-mediated Tissue Repair after Ischemia Through Cry61

E0009 Multimodality Molecular Imaging of Adipose-Derived Mesenchymal Stem Cells with VEGF in Hindlimb Ischaemia Mice

E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model

Implantation of Placenta-Derived Mesenchymal Stem Cells Accelerates Murine Dermal Wound Closure Through Immunomodulation.